M. Chen, Y. Ge, L. Dworkin, and R. Gong, “Glycogen synthase kinase (GSK) 3beta hyperactivity impairs glomerular podocyte insulin signaling via IRS1 modulation in diabetic kidney disease”, Translation, vol. 13, no. S3, Jun. 2025.